Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (331-340 of 682) with videos related to

Pageof 69
Sort By:
Journal of the National Cancer Institute|September 15, 1993
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancerM F Kohler, J R Marks, R W Wiseman, et al.
Human Pathology|November 1, 1996
Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinomaF A van den Brule, C Buicu, A Berchuck, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1993
Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinomaK A Leopold, J R Oleson, D Clarke-Pearson, et al.
Gynecologic Oncology|June 6, 2021
Cardiovascular medications and survival in people with ovarian cancer: A population-based cohort study from British Columbia, CanadaGillian E Hanley, Paramdeep Kaur, Andrew Berchuck, et al.
Gynecologic Oncology|December 17, 2009
Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotypeJason C Barnett, Sarah M Bean, Regina S Whitaker, et al.
Gynecologic Oncology|March 19, 2019
A pilot study of lower extremity lymphedema, lower extremity function, and quality of life in women after minimally invasive endometrial cancer staging surgeryCatherine H Watson, Micael Lopez-Acevedo, Gloria Broadwater, et al.
International Journal of Cancer|July 31, 2009
Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancerPaula S Lee, Vanessa S Teaberry, Amy E Bland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2012
A phase I trial of dasatinib, an SRC-family kinase inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancerAngeles Alvarez Secord, Deanna K Teoh, William T Barry, et al.
Virchows Archiv : an International Journal of Pathology|July 12, 2002
Cell proliferation and apoptosis in human uterine leiomyomas and myometriaDarlene Dixon, Gordon P Flake, Alicia B Moore, et al.
Gynecologic Oncology|December 31, 2002
Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancerLaura J Havrilesky, Angeles A Alvarez, Robyn A Sayer, et al.
Pageof 69

Showing results (331-340 of 682) with videos related to

Sort By:
Pageof 69
Journal of the National Cancer Institute|September 15, 1993
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancerM F Kohler, J R Marks, R W Wiseman, et al.
Human Pathology|November 1, 1996
Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinomaF A van den Brule, C Buicu, A Berchuck, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1993
Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinomaK A Leopold, J R Oleson, D Clarke-Pearson, et al.
Gynecologic Oncology|June 6, 2021
Cardiovascular medications and survival in people with ovarian cancer: A population-based cohort study from British Columbia, CanadaGillian E Hanley, Paramdeep Kaur, Andrew Berchuck, et al.
Gynecologic Oncology|December 17, 2009
Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotypeJason C Barnett, Sarah M Bean, Regina S Whitaker, et al.
Gynecologic Oncology|March 19, 2019
A pilot study of lower extremity lymphedema, lower extremity function, and quality of life in women after minimally invasive endometrial cancer staging surgeryCatherine H Watson, Micael Lopez-Acevedo, Gloria Broadwater, et al.
International Journal of Cancer|July 31, 2009
Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancerPaula S Lee, Vanessa S Teaberry, Amy E Bland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2012
A phase I trial of dasatinib, an SRC-family kinase inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancerAngeles Alvarez Secord, Deanna K Teoh, William T Barry, et al.
Virchows Archiv : an International Journal of Pathology|July 12, 2002
Cell proliferation and apoptosis in human uterine leiomyomas and myometriaDarlene Dixon, Gordon P Flake, Alicia B Moore, et al.
Gynecologic Oncology|December 31, 2002
Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancerLaura J Havrilesky, Angeles A Alvarez, Robyn A Sayer, et al.
Pageof 69